← Back to Search

Other

Pain Management Medications for Post-Operative Pain in Broken Arm

Phase 4
Recruiting
Led By Rachel M Thompson, MD
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Type II and III supracondylar humerus fracture
Isolated supracondylar humerus fracture
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after surgery at time of randomization until the patient returns for 1st post-operative visit, 7-10 days post-operatively, assessed up to 10 days.
Awards & highlights

Study Summary

This trial is investigating whether using ibuprofen and acetaminophen to control pain after surgery is as effective as using acetaminophen and oxycodone, and if it leads to less opioid prescriptions.

Who is the study for?
This trial is for children with certain types of elbow fractures (Type II and III supracondylar humerus fractures) that have been treated surgically. It's not suitable for kids with additional injuries, vascular or nerve damage, swelling needing hospitalization, allergies to the pain meds being tested, or those who can't use the Faces Pain Scale due to developmental delays.Check my eligibility
What is being tested?
The study compares two post-surgery pain management approaches in children: one combines acetaminophen (a common over-the-counter pain reliever) with ibuprofen (another OTC anti-inflammatory), while the other pairs acetaminophen with oxycodone (a stronger prescription opioid). The effectiveness will be measured by how well they control pain and parent/patient satisfaction.See study design
What are the potential side effects?
Acetaminophen may cause liver issues if used too much. Ibuprofen can lead to stomach upset or bleeding. Oxycodone is a strong medication that might cause constipation, nausea, drowsiness, breathing problems and has a risk of dependency.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have a type II or III break in the bone above my elbow.
Select...
I have a fracture in the bone above my elbow.
Select...
I have a broken bone above my elbow that hasn't pierced the skin.
Select...
I had a fracture fixed without surgery, using pins.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after surgery at time of randomization until the patient returns for 1st post-operative visit, 7-10 days post-operatively, assessed up to 10 days.
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after surgery at time of randomization until the patient returns for 1st post-operative visit, 7-10 days post-operatively, assessed up to 10 days. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Faces Pain Scale-Revised (FPSR)
Secondary outcome measures
Total Quality Pain Management Instrument
Other outcome measures
Pain medication logs

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: IbuprofenExperimental Treatment2 Interventions
This group is given acetaminophen (liquid oral medication, 15mg/kg/dose every 6 hours as needed, max 90mg/kg/day) as the first-line pain medication, and as needed ibuprofen for breakthrough pain (liquid oral medication, 10mg/kg/dose every 8 hours as needed, max dose 40mg/kg/day).
Group II: OxycodoneActive Control2 Interventions
This group is given acetaminophen (liquid oral medication, 15mg/kg/dose every 6 hours as needed, max 90mg/kg/day) as the first-line pain medication, and as needed oxycodone for breakthrough pain (liquid oral medication, 0.1mg/kg/dose every 6 hours as needed).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Acetaminophen
2017
Completed Phase 4
~2030
Ibuprofen
2013
Completed Phase 4
~5800

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,532 Previous Clinical Trials
10,265,178 Total Patients Enrolled
Rachel M Thompson, MDPrincipal InvestigatorUCLA/OIC
3 Previous Clinical Trials
124 Total Patients Enrolled

Media Library

Acetaminophen and Ibuprofen (Other) Clinical Trial Eligibility Overview. Trial Name: NCT03759028 — Phase 4
Supracondylar Humerus Fractures Research Study Groups: Ibuprofen, Oxycodone
Supracondylar Humerus Fractures Clinical Trial 2023: Acetaminophen and Ibuprofen Highlights & Side Effects. Trial Name: NCT03759028 — Phase 4
Acetaminophen and Ibuprofen (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03759028 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~9 spots leftby Dec 2024